Kallidin

Known as: Kallidin [Chemical/Ingredient], Lys Bradykinin, kallidin II 
A decapeptide bradykinin homolog cleaved from kininogen by kallikreins. It is a smooth-muscle stimulant and hypotensive agent that acts by… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
BACKGROUND Studies in animals and humans indicate a role for kinins in the actions of angiotensin type 1 (AT1) receptor blockers… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Both bradykinin B2 and angiotensin II type 2 (AT2) receptors are known to stimulate renal production of nitric oxide (NO). To… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
In this study we report the cloning and characterization of a novel human aminopeptidase, which we designate leukocyte-derived… (More)
Is this relevant?
1999
1999
BACKGROUND Since kinins kallidin (KD) and bradykinin (BK) appear to have cardioprotective effects ranging from improved… (More)
  • figure 2
  • table 1
  • figure 3
  • table 2
  • table 3
Is this relevant?
1995
1995
Bradykinin (BK) and kallidin (KAL) derivatives containing a Cys residue instead of a Ser residue at positions 6 and 7… (More)
Is this relevant?
1990
1990
Bradykinin, kallidin (lys-bradykinin), and [des-Arg9]bradykinin are oligopeptides that may contribute as mediators in the… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
The first sequence-related competitive inhibitors of the classic kinin in vitro (rat uterus guinea pig ileum) and in vivo (rat… (More)
Is this relevant?
1977
1977
When canine tracheal explants were incubated in culture medium 199 in the presence of D-glucosamine labeled with carbon-14 for 24… (More)
Is this relevant?
Review
1964
Review
1964
Biochemie und Pharmakologie der drei natürlich vorkommenden und in der Struktur bekannten Kinine — Bradykinin, Kallidin und… (More)
  • figure 1
  • figure 5
  • figure 8
  • table I
  • figure 9
Is this relevant?